サンプル依頼リスト カート
  • English
  • Korean
表紙：憩室炎の世界市場レポート 2024年
市場調査レポート
商品コード
1415737

憩室炎の世界市場レポート 2024年

Diverticulitis Disease Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
憩室炎の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

憩室炎の市場規模は近年急速に拡大しています。2023年の16億8,000万米ドルから2024年には18億5,000万米ドルに、CAGR10.4％で拡大します。実績期間の成長は、高齢化、食生活、肥満、医療用画像の進歩に起因します。

消化器疾患に対する薬剤や治療に対するニーズの高まりは、当面の憩室炎市場の拡大を推進する重要な要因になると予測されています。消化器疾患には、食物からの栄養素の分解・吸収を担う消化器系に影響を及ぼす幅広い疾患が含まれます。大腸がんを含むこれらの疾患は、憩室の形成を助長し、大腸の袋における細菌の停滞を助長することにより、憩室炎のリスクを高める可能性があります。例えば、2022年9月現在、国際がん研究機関は、2040年までに大腸がんに起因する年間320万人の新規患者と160万人の死亡者が発生すると推定しており、2020年の190万人の新規診断患者と93万人の死亡者から顕著な増加を示しています。その結果、消化器疾患の治療薬や治療に対する需要の高まりが、憩室炎市場の成長の原動力となっています。

2023年の憩室炎市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。憩室炎レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の憩室炎疾患市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • シンプル
  • 複雑
  • 世界の憩室炎疾患市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コンピュータ断層撮影（CT）スキャン
  • 超音波
  • 尿検査
  • 血液検査
  • 世界の憩室炎疾患市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬剤
  • 手術
  • 支持療法
  • ペニシリン系抗生物質
  • 抗生物質
  • 栄養補助食品
  • 静脈内（IV）輸液
  • 世界の憩室炎疾患市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 専門センター
  • 病院
  • 研究センター

第7章 地域および国の分析

  • 世界の憩室炎疾患市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の憩室炎疾患市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 憩室炎疾患市場の競合情勢
  • 憩室炎疾患市場企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson
    • F. Hoffmann-La Roche AG
    • Merck &Co. Inc.
    • AbbVie Inc.

第31章 その他の主要および革新的な企業

  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Amgen Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma
  • Eisai Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12336

“Diverticulitis Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diverticulitis disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diverticulitis disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The diverticulitis disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Uncomplicated; Complicated
  • 2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
  • 3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
  • 4) By End-User: Specialty Centers; Hospitals; Research centers
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Diverticulitis disease is a medical condition marked by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. Symptoms may encompass lower abdominal pain, constipation, diarrhea, and rectal bleeding.

The disease is categorized into two main types sush as uncomplicated and complicated. Uncomplicated diverticulitis refers to the inflammation or infection of these small pouches, known as diverticula, within the colon walls. Various diagnostic methods such as computed tomography (CT) scans, ultrasounds, urine tests, and blood tests are employed. Treatment options encompass medications, surgery, supportive care, penicillin antibiotics, other antibiotics, dietary supplements, and intravenous (IV) fluids. These treatments are utilized by diverse end-users, including specialty centers, hospitals, and research centers.

The diverticulitis disease market research report is one of a series of new reports from The Business Research Company that provides diverticulitis disease market statistics, including diverticulitis disease industry global market size, regional shares, competitors with a diverticulitis disease market share, detailed diverticulitis disease market segments, market trends and opportunities and any further data you may need to thrive in the diverticulitis disease industry. This diverticulitis disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.

The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.

The increasing need for drugs and treatments for digestive disorders is projected to be a significant factor propelling the expansion of the diverticulitis disease market in the foreseeable future. Digestive disorders encompass a broad spectrum of conditions affecting the digestive system, responsible for the breakdown and absorption of nutrients from food. These disorders, including colorectal cancer, can heighten the risk of diverticulitis by contributing to the formation of diverticula and fostering bacterial stagnation in the colon's pouches. For instance, as of September 2022, the International Agency for Research on Cancer estimated that by 2040, there would be an annual occurrence of 3.2 million new cases and 1.6 million deaths attributed to colorectal cancer, signifying a notable increase from 1.9 million newly diagnosed patients and 930,000 deaths in 2020. Consequently, the rising demand for drugs and treatments for digestive disorders serves as a driving force behind the growth of the diverticulitis disease market.

The escalating prevalence of inflammatory bowel diseases (IBD) is anticipated to be a significant driver for the growth of the diverticulitis disease market in the coming years. Inflammatory bowel disease refers to a group of chronic inflammatory disorders primarily impacting the gastrointestinal (GI) tract. It is noteworthy that diverticulitis can initially present symptoms akin to IBD, and there is evidence of low-grade chronic inflammation in individuals with diverticula. The prevailing theory is that diverticulitis arises from mucosal inflammation induced by immune system activation. For instance, as reported by BioMed Central Ltd. in May 2021, it is projected that between 2020 and 2035, there will be an estimated 69 thousand cases of inflammatory bowel disease in Iran, 220 thousand cases in the Middle East, 2.2 million cases in India, and 4.5 million cases in East Asia. Consequently, the increasing incidence of inflammatory bowel diseases is a key driver behind the growth of the diverticulitis disease market.

Major players in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

A deficit in disease awareness is expected to impede the growth of the diverticulitis disease market in the coming years. Insufficient knowledge about diverticulitis among the general population can lead to delayed diagnosis and treatment, potentially exacerbating the condition. For example, as of June 2023, the National Library of Medicine reported that individuals experiencing symptoms like pain in the lower left abdomen, fever, nausea and vomiting, diarrhea, and loss of appetite often delay seeking care due to feelings of embarrassment or a fear of potentially undergoing gastrointestinal surgery with a colostomy bag as their sole treatment option. Consequently, the lack of awareness about the disease acts as a hindrance to the growth of the diverticulitis disease market.

Prominent companies in the diverticulitis disease market are actively engaged in the development of innovative drugs and securing regulatory approvals, a strategic move to bolster their market position. This endeavor holds the potential to yield more effective treatment options for diverticulitis, thereby mitigating the risk of complications and enhancing patient outcomes. For example, in April 2023, the United States Food and Drug Administration, a federal organization based in the US, granted approval for Seres' microbiota drug tailored for recurrent gut infections. This drug is designed to address recurring gut infections and preempt the resurgence of Clostridioides difficile (C. diff.) infections in adults aged 18 and above.

Surge In Healthcare Expenditure Drives Advancements In Diverticulitis Disease Care

North America was the largest region in the diverticulitis disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diverticulitis disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diverticulitis disease market consists of revenues earned by entities by providing diagnostic services, pain management, nutritional therapy and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diverticulitis disease market also includes sales of antibiotics, dietary supplements, high-fiber foods and pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Diverticulitis Disease Market Characteristics

3. Diverticulitis Disease Market Trends And Strategies

4. Diverticulitis Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Diverticulitis Disease Market Size and Growth

  • 5.1. Global Diverticulitis Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Diverticulitis Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Diverticulitis Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diverticulitis Disease Market Segmentation

  • 6.1. Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Uncomplicated
  • Complicated
  • 6.2. Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Computed Tomography (CT) Scan
  • Ultrasound
  • Urine Test
  • Blood Test
  • 6.3. Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medications
  • Surgery
  • Supportive care
  • Penicillin Antibiotic
  • Antibiotics
  • Dietary Supplements
  • Intravenous (IV) Fluids
  • 6.4. Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Specialty Centers
  • Hospitals
  • Research centers

7. Diverticulitis Disease Market Regional And Country Analysis

  • 7.1. Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diverticulitis Disease Market

  • 8.1. Asia-Pacific Diverticulitis Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diverticulitis Disease Market

  • 9.1. China Diverticulitis Disease Market Overview
  • 9.2. China Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diverticulitis Disease Market

  • 10.1. India Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diverticulitis Disease Market

  • 11.1. Japan Diverticulitis Disease Market Overview
  • 11.2. Japan Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diverticulitis Disease Market

  • 12.1. Australia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diverticulitis Disease Market

  • 13.1. Indonesia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diverticulitis Disease Market

  • 14.1. South Korea Diverticulitis Disease Market Overview
  • 14.2. South Korea Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diverticulitis Disease Market

  • 15.1. Western Europe Diverticulitis Disease Market Overview
  • 15.2. Western Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diverticulitis Disease Market

  • 16.1. UK Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diverticulitis Disease Market

  • 17.1. Germany Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diverticulitis Disease Market

  • 18.1. France Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diverticulitis Disease Market

  • 19.1. Italy Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diverticulitis Disease Market

  • 20.1. Spain Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diverticulitis Disease Market

  • 21.1. Eastern Europe Diverticulitis Disease Market Overview
  • 21.2. Eastern Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diverticulitis Disease Market

  • 22.1. Russia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diverticulitis Disease Market

  • 23.1. North America Diverticulitis Disease Market Overview
  • 23.2. North America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diverticulitis Disease Market

  • 24.1. USA Diverticulitis Disease Market Overview
  • 24.2. USA Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diverticulitis Disease Market

  • 25.1. Canada Diverticulitis Disease Market Overview
  • 25.2. Canada Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diverticulitis Disease Market

  • 26.1. South America Diverticulitis Disease Market Overview
  • 26.2. South America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diverticulitis Disease Market

  • 27.1. Brazil Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diverticulitis Disease Market

  • 28.1. Middle East Diverticulitis Disease Market Overview
  • 28.2. Middle East Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diverticulitis Disease Market

  • 29.1. Africa Diverticulitis Disease Market Overview
  • 29.2. Africa Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diverticulitis Disease Market Competitive Landscape And Company Profiles

  • 30.1. Diverticulitis Disease Market Competitive Landscape
  • 30.2. Diverticulitis Disease Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Diverticulitis Disease Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi S.A.
  • 31.4. Bristol-Myers Squibb Company
  • 31.5. AstraZeneca plc
  • 31.6. Abbott Laboratories
  • 31.7. GlaxoSmithKline plc
  • 31.8. Takeda Pharmaceutical Company Limited
  • 31.9. Eli Lilly and Company
  • 31.10. Amgen Inc.
  • 31.11. Viatris Inc.
  • 31.12. Teva Pharmaceutical Industries Ltd.
  • 31.13. Astellas Pharma
  • 31.14. Eisai Co. Ltd.
  • 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Diverticulitis Disease Market Competitive Benchmarking

33. Global Diverticulitis Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Diverticulitis Disease Market

35. Diverticulitis Disease Market Future Outlook and Potential Analysis

  • 35.1 Diverticulitis Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Diverticulitis Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Diverticulitis Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer